Dr.Peihua Peggy Lu hematolog

Dr. Peihua (Peggy) Lu, MD

Medical Executive President of Lu Daopei Hospital and Lu Daopei Institute of Hematology

Dr. Lu graduated from Peking University  Medical School, and had her residency training at the University of Nebraska Medical Center in USA. She completed her hematology and  oncology fellowship at Stanford University Medical Center.

• American Board Certified Hematologist & Oncologist,  with American and Chinese Medical License.
• Chairman of Hematology Specialty Committee of  Chinese Non-government Medical Institutions Association (CNMIA)
• Member of Chinese Marrow Donor Program(CMDP) Expert Committee
• Member of  Chinese Society of Clinical Oncology (CSCO) Anti-Leukemia Alliance Expert Committee
• Member of the Hematology Translational Medicine Committee of China Anti-Cancer Association（CACA）
• Vice Chairman of Sanhe Private Hospital Industry Association

İdari Randevular

Lu Daopei Hastanesi Tıbbi Yönetici Başkanı
Director of Lymphoma and Multipl Miyelom Merkez

Hematoloji ve Onkoloji bölüm müdürü

Klinik odak

Leukemia, Multiple myeloma, Lymphoma, Aplastic anemia, and acute and chronic myeloproliferative hastalığı.

CAR-T hücre immünoterapisi.

Kurul Sertifikası

American Board Onaylı Hematoloji ve Onkoloji

American medical license of Hematology & oncology; Chinese medical license

Member of ASH, ASCO, and CAHON

CNMIA icra kurulu üyesinin ilk oturumu

CNMIA Hematoloji Uzmanlık Komitesi Başkanı

Eğitim

Dr. Lu, Pekin Üniversitesi Tıp Fakültesi'nden mezun oldu, ikamet eğitimini Nebraska Üniversitesi Tıp Merkezi'nde aldı. Hematoloji ve onkoloji bursunu Stanford Üniversitesi Tıp Merkezi'nde tamamladı.

İş Deneyimi

Lu Daopei Hastanesi Tıbbi Yönetici Başkanı

Başarılar

She has had many awards, including National Cancer Institute individual fellowship award, physician scientist award (K011) from National Cancer institute.

She was invited as the speaker for a personal success Öykü at the annual American College of Physician conference in 1996, elected America’s top oncologist 2012 by Consumers’ Research Council of America.

Kemik İliği Kök Hücre Nakli

CAR-T Hücre tedavisi